This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
4bul
From Proteopedia
| Line 1: | Line 1: | ||
{{STRUCTURE_4bul| PDB=4bul | SCENE= }} | {{STRUCTURE_4bul| PDB=4bul | SCENE= }} | ||
===Novel hydroxyl tricyclics (e.g. GSK966587) as potent inhibitors of bacterial type IIA topoisomerases=== | ===Novel hydroxyl tricyclics (e.g. GSK966587) as potent inhibitors of bacterial type IIA topoisomerases=== | ||
| - | {{ | + | {{ABSTRACT_PUBMED_23968823}} |
==Function== | ==Function== | ||
| Line 8: | Line 8: | ||
==About this Structure== | ==About this Structure== | ||
[[4bul]] is a 6 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4BUL OCA]. | [[4bul]] is a 6 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4BUL OCA]. | ||
| + | |||
| + | ==See Also== | ||
| + | *[[Gyrase|Gyrase]] | ||
==Reference== | ==Reference== | ||
| - | <ref group="xtra">PMID: | + | <ref group="xtra">PMID:023968823</ref><references group="xtra"/><references/> |
[[Category: Bax, B.]] | [[Category: Bax, B.]] | ||
[[Category: Brooks, G.]] | [[Category: Brooks, G.]] | ||
Revision as of 08:56, 4 September 2013
Contents |
Novel hydroxyl tricyclics (e.g. GSK966587) as potent inhibitors of bacterial type IIA topoisomerases
Template:ABSTRACT PUBMED 23968823
Function
[GYRB_STAAN] DNA gyrase negatively supercoils closed circular double-stranded DNA in an ATP-dependent manner and also catalyzes the interconversion of other topological isomers of double-stranded DNA rings, including catenanes and knotted rings (By similarity).
About this Structure
4bul is a 6 chain structure. Full crystallographic information is available from OCA.
See Also
Reference
- Miles TJ, Hennessy AJ, Bax B, Brooks G, Brown BS, Brown P, Cailleau N, Chen D, Dabbs S, Davies DT, Esken JM, Giordano I, Hoover JL, Huang J, Jones GE, Kusalakumari Sukmar SK, Spitzfaden C, Markwell RE, Minthorn EA, Rittenhouse S, Gwynn MN, Pearson ND. Novel hydroxyl tricyclics (e.g., GSK966587) as potent inhibitors of bacterial type IIA topoisomerases. Bioorg Med Chem Lett. 2013 Jul 17. pii: S0960-894X(13)00847-0. doi:, 10.1016/j.bmcl.2013.07.013. PMID:23968823 doi:10.1016/j.bmcl.2013.07.013
Categories: Bax, B. | Brooks, G. | Brown, B S. | Brown, P. | Cailleau, N. | Chen, D. | Dabbs, S. | Davies, D T. | Esken, J M. | Giordano, I. | Gwynn, M N. | Hennessy, A J. | Hoover, J L. | Huang, J. | Jones, G E. | Markwell, R E. | Miles, T J. | Minthorn, E A. | Pearson, N D. | Rittenhouse, S. | Spitzfaden, C. | Sukmar, S K.K. | Isomerase | Nbti | Type iia topoisomerase
